Determination of levetiracetam in human plasma with minimal sample pretreatment
- 5 May 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Chromatography B
- Vol. 819 (1), 197-200
- https://doi.org/10.1016/j.jchromb.2005.01.040
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- High‐performance liquid chromatographic determination of Levetiracetam in human plasma: comparison of different sample clean‐up proceduresBiomedical Chromatography, 2003
- Levetiracetam: Relative Bioavailability and Bioequivalence of a 10% Oral Solution (750 mg) and 750‐mg TabletsThe Journal of Clinical Pharmacology, 2003
- Microemulsion electrokinetic chromatography applied for separation of levetiracetam from other antiepileptic drugs in polypharmacyElectrophoresis, 2003
- Pharmacokinetic Study of Levetiracetam in ChildrenEpilepsia, 2001
- Levetiracetam: A Novel Antiepileptic DrugPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2001
- Enantioselective analysis of levetiracetam and its enantiomer R-α-ethyl-2-oxo-pyrrolidine acetamide using gas chromatography and ion trap mass spectrometric detectionJournal of Chromatography B: Biomedical Sciences and Applications, 2000
- Bioanalytical Method Validation—A Revisit with a Decade of ProgressPharmaceutical Research, 2000
- The Clinical Pharmacokinetics of the Newer Antiepileptic DrugsClinical Pharmacokinetics, 1996
- A Micromethod for the Determination of the New Antiepileptic Drug Levetiracetam (ucb LO59) in Serum or Plasma by High Performance Liquid ChromatographyTherapeutic Drug Monitoring, 1996
- High-performance liquid chromatographic and megabore gas—liquid chromatographic determination of levetiracetam (ucb L059) in human serum after solid-phase extractionJournal of Chromatography B: Biomedical Sciences and Applications, 1994